Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension

Chinese Medical Journal

Volumn 121, Issue 24, 2008, Pages 2497-2503

  Jiang, Xin ^a   Han, Zhi Yan ^a   Wang, Yong ^b   Xu, Xi Qi ^c   Ma, Chuan Rong ^c   Wu, Yan ^a   Pan, Lei ^b   Jing, Zhi Cheng ^c  

^a FUWAI HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Follow up studies; Hypertension, pulmonary; Uric acid

Indexed keywords

BOSENTAN; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; SILDENAFIL; URIC ACID; VARDENAFIL; VASODILATOR AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOPULMONARY HEMODYNAMICS; CHILD; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEART OUTPUT; HEART RIGHT VENTRICLE; HEART SIZE; HUMAN; IDIOPATHIC DISEASE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PULMONARY HYPERTENSION; TREATMENT DURATION; URIC ACID BLOOD LEVEL; VENOUS OXYGEN TENSION;

EID: 60649109875     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200812020-00006     Document Type: Article

References (28)

1. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115: 343-349.
2. Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW, Wang H, et al. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007; 132: 373-379.
3. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl S): 40-47.
4. Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (1 Suppl): 35-62.
5. Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-2278.
6. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Uar Heart J 1997; 18: 858-865.
7. Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJ. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart 1997; 78: 39-43.
8. Hayabuchi Y, Matsuoka S, Akita H, Kuroda Y. Hyperuricemia in cyanotic congenital heart disease. Uar J Pediatr 1993; 152: 873-876.
9. Hasday JD, Grum CM. Nocturnal increase of urinary uric acid:creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis 1987; 135: 534-538.
10. Braghiroli A, Sacco C, Erbetta M, Ruga V, Donner CF. Overnight urinary acid:creatinine ratio for detection of sleep hypoxia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 1993; 148: 173-178.
11. Elsayed NM, Nakashima JM, Postlethwait EM. Measurement of uric acid as a marker of oxygen tension in the lung. Arch Biochem Biophys 1993; 302: 228-232.
12. Fox AC, Reed GE, Meilman H, Silk BB. Release of nucleosides from canine and human hearts as an index of prior ischemia. Am J Cardiol 1979; 3: 52-58.
13. Mentzer RM Jr, Rubio R, Berne RM. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol 1975; 229: 1625-1631.
14. Leyva F, Chua TP, Anker SD, Coats AJ. Uric acid in chronic heart failure: a measure of anaerobic threshold. Metabolism 1998; 47: 1156-1159,
15. Nagaya N, Uematsu M, Satoh T, Kyotam S, Sakamaki F, Nakanishi N, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 1999; 160: 487-492.
16. Oya H, Nagaya N, Satoh T, Sakamaki F, Kyotani S, Fujita M, et al. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart 2000; 84: 53-58.
17. Njaman W, Iesaki T, Iwama Y, Takasaki Y, Daida H. Serum uric acid as a prognostic predictor in pulmonary arterial hypertension with connective tissue disease. Int Heart J 2007; 48: 523-532.
18. Shao SF, Zeng G. The correlation analysis of hyperuricemia and pulmonary arterial hypertension. Qinghai Med J (Chin) 2002; 32: 1-2.
19. Huizer T, de Jong JW, Nelson JA, Czarnecki W, Serruys PW, Bonnier JJ, et al. Urate production by human heart. J Mol Cell Cardiol 1989; 21: 691-695.
20. McCord JM, Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163.
21. Ross EA, Perloff JK, Danovitch GM, Child JS, Canobbio MM. Renal function and urate metabolism in late survivors with cyanotic congenital heart disease. Circulation 1986; 73: 396-400.
22. Galie N, Manes A, Farahani KV, Pelino F, Palazzini M, Negro L, et al. Pulmonary arterial hypertension associated to-connective tissue diseases. Lupus 2005; 14:713-717.
23. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Uar Respir J 2003; 22: 358-363.
24. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosaila C, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003; 107: 1991-1997.
25. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol 2006; 62: 1-12.
26. Messerli FH, Frohlich G, Dreslinski D, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980; 93: 817-821.
27. Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-870.
28. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001; 120: 1562-1569.